GlaxoSmithKline
GSK
#279
Rank
C$103.90 B
Marketcap
$50.93
Share price
0.86%
Change (1 day)
-2.78%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $4.72

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.04. In 2022 the company made an earnings per share (EPS) of $12.22 an increase over its 2021 EPS that were of $4.31.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.72-61.34%
2022$12.22183.39%
2021$4.31-17.83%
2020$5.2521.82%
2019$4.3123.91%
2018$3.48141.48%
2017$1.4464.6%
2016$0.87-90.64%
2015$9.34178.14%
2014$3.36-48.16%
2013$6.4822.63%
2012$5.28-11.32%
2011$5.96230.25%
2010$1.80-70.98%
2009$6.226.76%
2008$5.82-15.14%
2007$6.867.82%
2006$6.3619.61%
2005$5.3218.56%
2004$4.490.36%
2003$4.4750.39%
2002$2.9731.13%
2001$2.27-25.43%
2000$3.0431.58%
1999$2.311.05%
1998$2.29-0.98%
1997$2.31-10.07%
1996$2.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.86-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.68-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.62-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.39 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.58-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$2.88-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.25-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA